How does it work?

Enterogermina® 4 Billion is developed with kids and families in mind. It works gently in harmony with the body to restore and maintain your family’s gut health.

Gastro-resistant

Bacillus clausii contained in Enterogermina® 4 Billion is resistant to gastric acid ensuring it survives digestive transit. This means that Enterogermina® is active where it needs to be, in the intestine. 2

Polyantibiotic-resistant

Bacillus clausii contained in Enterogermina® is resistant to most commonly used antibiotics because of the 4-strains included; O/C, SIN, N/R and T. 2,3

Intestinal flora

Enterogermina® 4 Billion contains Bacillus clausii spores that make their way into the digestive tract with the intent to restore intestinal flora so that symptom relief and prevention may occur. 1

Benefits of Enterogermina® 4 Billion

Helps maintain a healthy gut

Helps restore microbial flora

Helps protect against gut disturbances

Practical Info

1

Shake well

2

Snap the top to open

3

Swallow the contents

Dosage

Infants and Children (older than 1+ months)

1 vial per day in regular intervals as directed. This medication is for oral use only. Do not inject or administer in any other way. Shake the vial before use.

Adults (from 12 years)

1 vial per day as directed. This medication is for oral use only. Do not inject or administer in any other way. Shake the vial before use.

Frequently Asked Questions

Enterogermina® works with the body to assist in restoring the natural balance in the gut. You probably have a few questions for us. Check out our FAQ and download a copy of our leaflet to keep.

  • The effects of Enterogermina® can be seen within 1 to 3 days of starting use of the product.

    Enterogermina® can be taken during antibiotic therapy. During the course, and in the following 7 to 10 days, Enterogermina® 4 Billion is able to reduce the incidence of adverse events including abdominal pain and diarrhoea.1

  • Absolutely. Enterogermina® is a gentle solution that won’t irritate the stomach. Similarly, taking Enterogermina® after a meal won’t inhibit the formula from getting where it needs to go. 1

  • If you are pregnant, may be pregnant, are planning to become pregnant, or are breastfeeding, talk to your doctor or pharmacist before taking this medicine. 1

  • The Enterogermina® range is made in Italy. 1

  • The Enterogermina® range is best stored at room temperature (no higher than 25°C), and away from direct light and moisture. 1

  • Each pack of Enterogermina® 4 Billion contains 20 vials, and each vial contains 4 billion Bacillus clausii spores1

  • The potential side effects of Enterogermina® are:

    Potential reactions of hypersensitivity either towards the components of the drug or other closely related substances.

    Minor rashes, bacteraemia, septicaemia or sepsis in immuno-compromised patients or those hospitalised due to a serious illness.

    Urticaria as a result of allergic reaction. 

    Should your general health worsen or if you experience any untoward effects while taking this medicine, please consult your healthcare provider for advice. 1

  • If you are pregnant, may be pregnant, are planning to become pregnant, or are breastfeeding, talk to your doctor or pharmacist before taking this medicine. 1

Browse Our Products

Enterogermina® works with the body in delivering good bacteria in order to assist in the prevention of intestinal disorders, maintain gut health, and balance the microbiota in adults and children.

Stay Informed

Learn how different daily triggers could be contributing to intestinal disorders, and how a good probiotic could be the ally you didn't know you needed.

    * Nicholas Hall's CHC database, DB6, 2022

    1. Product information Enterogermina 4B
    2. Ghelardi E, et al. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. J Appl Microbiol. 2015;119(2):552-9.
    3. Abbrescia A, et al. Antibiotic Sensitivity of Bacillus clausii Strains in Commercial Preparation. Clinical Immunology, Endocrine & Metabolic Drugs 2014; 1:102-110